Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nexalin Technology (NXL) Common Equity (2022 - 2025)

Historic Common Equity for Nexalin Technology (NXL) over the last 4 years, with Q3 2025 value amounting to $4.8 million.

  • Nexalin Technology's Common Equity fell 381.98% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year decrease of 381.98%. This contributed to the annual value of $3.7 million for FY2024, which is 1463.85% up from last year.
  • Per Nexalin Technology's latest filing, its Common Equity stood at $4.8 million for Q3 2025, which was down 381.98% from $6.0 million recorded in Q2 2025.
  • Nexalin Technology's 5-year Common Equity high stood at $6.4 million for Q3 2022, and its period low was $1.4 million during Q2 2024.
  • For the 4-year period, Nexalin Technology's Common Equity averaged around $4.0 million, with its median value being $4.0 million (2023).
  • In the last 5 years, Nexalin Technology's Common Equity plummeted by 6616.52% in 2024 and then soared by 34139.9% in 2025.
  • Nexalin Technology's Common Equity (Quarter) stood at $5.5 million in 2022, then tumbled by 41.47% to $3.2 million in 2023, then increased by 14.64% to $3.7 million in 2024, then rose by 29.72% to $4.8 million in 2025.
  • Its Common Equity stands at $4.8 million for Q3 2025, versus $6.0 million for Q2 2025 and $2.3 million for Q1 2025.